FDA Inspection 1230726 - GlaxoSmithKline LLC - August 16, 2024
FDA Inspection 1230726 for GlaxoSmithKline LLC on August 16, 2024. Classification: No Action Indicated (NAI).
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
FDA Inspection 1230726 for GlaxoSmithKline LLC on August 16, 2024. Classification: No Action Indicated (NAI).
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Company
GlaxoSmithKline LLCInspection Date
August 16, 2024
Product Type
Drugs
ID: 13c32f4d-414a-4526-845d-350d12295277
View on DashboardTransform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox